Screener
Capricor Therapeutics CAPR Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Capricor Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect.
The source filing: Capricor Therapeutics’s 10-Q, filed May 13, 2026. Open the filing →
- Filed
- May 13, 2026, 5:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-060382
FAQ
- What is Capricor Therapeutics's net change in cash?
- Capricor Therapeutics (CAPR) reported net change in cash of -$182.43M in Q1 2026.
- How has Capricor Therapeutics's net change in cash changed year-over-year?
- Capricor Therapeutics's net change in cash decreased by 1142.0% year-over-year, from $17.51M to -$182.43M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.
Ask your AI about Capricor Therapeutics's net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude